Similar articles for PMID: 30332838

Year	Number of Results
1993	1
1998	1
2000	1
2004	1
2005	2
2006	1
2007	4
2009	1
2010	6
2011	8
2012	1
2013	5
2014	6
2015	2
2016	8
2017	3
2018	6
2019	5
2020	11
2021	10
2022	11
2023	13
2024	4

1

Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases.

Teijido O, Cacabelos R. Teijido O, et al. Int J Mol Sci. 2018 Oct 16;19(10):3199. doi: 10.3390/ijms19103199. Int J Mol Sci. 2018. PMID: 30332838 Free PMC article. Review.

2

Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.

Ciceri F, Rotllant D, Maes T. Ciceri F, et al. Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140. Curr Pharm Des. 2017. PMID: 28120717 Review.

3

Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.

Cacabelos R. Cacabelos R. Drug Dev Res. 2014 Sep;75(6):348-65. doi: 10.1002/ddr.21219. Drug Dev Res. 2014. PMID: 25195579

4

Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.

Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA. Van Bulck M, et al. Int J Mol Sci. 2019 Feb 8;20(3):719. doi: 10.3390/ijms20030719. Int J Mol Sci. 2019. PMID: 30743990 Free PMC article. Review.

5

Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?

Harrison IF, Dexter DT. Harrison IF, et al. Pharmacol Ther. 2013 Oct;140(1):34-52. doi: 10.1016/j.pharmthera.2013.05.010. Epub 2013 May 24. Pharmacol Ther. 2013. PMID: 23711791 Review.

6

Epigenetic drug discovery for Alzheimer's disease.

Cacabelos R, Torrellas C. Cacabelos R, et al. Expert Opin Drug Discov. 2014 Sep;9(9):1059-86. doi: 10.1517/17460441.2014.930124. Epub 2014 Jul 3. Expert Opin Drug Discov. 2014. PMID: 24989365 Review.

7

Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.

Nobre RJ, Almeida LP. Nobre RJ, et al. Curr Pharm Des. 2011;17(31):3434-45. doi: 10.2174/138161211798072472. Curr Pharm Des. 2011. PMID: 21902665

8

Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.

Nohesara S, Abdolmaleky HM, Thiagalingam S, Zhou JR. Nohesara S, et al. Epigenomics. 2024 Jan;16(1):57-77. doi: 10.2217/epi-2023-0342. Epub 2023 Dec 13. Epigenomics. 2024. PMID: 38088063 Review.

9

Histone Methylation Regulation in Neurodegenerative Disorders.

Basavarajappa BS, Subbanna S. Basavarajappa BS, et al. Int J Mol Sci. 2021 Apr 28;22(9):4654. doi: 10.3390/ijms22094654. Int J Mol Sci. 2021. PMID: 33925016 Free PMC article. Review.

10

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases.

Mayo S, Benito-León J, Peña-Bautista C, Baquero M, Cháfer-Pericás C. Mayo S, et al. Curr Neuropharmacol. 2021;19(8):1273-1303. doi: 10.2174/1570159X19666201223154009. Curr Neuropharmacol. 2021. PMID: 33357195 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year